<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The reported cumulative risk of developing <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) patients undergoing ileal pouch-anal anastomosis (IPAA) approaches 50% after 10 years </plain></SENT>
<SENT sid="1" pm="."><plain>To date, no preoperative serological predictor of <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> has been found </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: To assess whether preoperative perinuclear antineutrophil cytoplasmic antibody (pANCA) expression was associated with <z:hpo ids='HP_0011009'>acute</z:hpo> and/or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> after IPAA </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Patients were prospectively assessed for the development of clinically and endoscopically proved <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Serum obtained at the time of colectomy in 95 UC patients undergoing IPAA was analysed for pANCA by ELISA and indirect immunofluorescence </plain></SENT>
<SENT sid="5" pm="."><plain>pANCA+ patients were stratified into high level (&gt;100 ELISA units (EU)/ml) (n=9), moderate level (40-100 EU/ml) (n=32), and low level (&lt;40 EU/ml) (n=19) subgroups </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Sixty of the 95 patients (63%) expressed pANCA </plain></SENT>
<SENT sid="7" pm="."><plain>After a median follow up of 32 months (range 1-89), 32 patients (34%) developed either <z:hpo ids='HP_0011009'>acute</z:hpo> (n=14) or <z:hpo ids='HP_0011010'>chronic</z:hpo> (n=18) <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">Pouchitis</z:e> was seen in 42% of pANCA+ patients compared with 20% of pANCA- patients (p=0.09) </plain></SENT>
<SENT sid="9" pm="."><plain>There was no significant difference in the incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> between the three pANCA+ patient subgroups </plain></SENT>
<SENT sid="10" pm="."><plain>The cumulative risk of developing <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> among patients with high level pANCA (56%) before colectomy was significantly higher than in patients with medium level (22%), low level (16%), and those who were pANCA- (20%) (p=0.005) </plain></SENT>
<SENT sid="11" pm="."><plain>Multivariate analysis revealed that the sole parameter significantly associated with the development of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> after IPAA was the presence of high level pANCA before colectomy (p=0.005) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: High level pANCA before colectomy is significantly associated with the development of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0376620" disease_type="Disease or Syndrome" abbrv="">pouchitis</z:e> after IPAA </plain></SENT>
</text></document>